Hepatitis Monthly

Published by: Kowsar

Association of Adiponectin Gene Polymorphisms With the Risk of Coronary Artery Disease in Patients With Nonalcoholic Fatty Liver Disease in a Chinese Han Population

Shui-Xian Du 1 , 2 , Lin-Lin Lu 3 , 4 , Yang Liu 1 , 2 , Quan-Jiang Dong 2 , 3 , Shi-Ying Xuan 1 , 2 , 3 , * and Yong-Ning Xin 1 , 2 , 3 , *
Authors Information
1 Medical College of Qingdao University, Qingdao, China
2 Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, China
3 Digestive Disease Key Laboratory of Qingdao, Qingdao, China
4 Central Laboratories, Qingdao Municipal Hospital, Qingdao, China
Corresponding Authors:
Article information
  • Hepatitis Monthly: July 01, 2016, 16 (7); e37388
  • Published Online: June 26, 2016
  • Article Type: Research Article
  • Received: February 24, 2016
  • Revised: May 11, 2016
  • Accepted: May 31, 2016
  • DOI: 10.5812/hepatmon.37388

To Cite: Du S, Lu L, Liu Y, Dong Q, Xuan S, et al. Association of Adiponectin Gene Polymorphisms With the Risk of Coronary Artery Disease in Patients With Nonalcoholic Fatty Liver Disease in a Chinese Han Population, Hepat Mon. 2016 ; 16(7):e37388. doi: 10.5812/hepatmon.37388.

Abstract
Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Kim S, Hong J, Jeon R, Kim HS. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease. Nutr Res. 2016; 36(1): 90-100[DOI][PubMed]
  • 2. Rinella M, Charlton M. The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health. Hepatology. 2016; 64(1): 19-22[DOI][PubMed]
  • 3. Vilar CP, Cotrim HP, Florentino GS, Bragagnoli G, Schwingel PA, Barreto CP. Nonalcoholic fatty liver disease in patients with coronary disease from a Brazil northeast area. Arq Gastroenterol. 2015; 52(2): 111-6[DOI][PubMed]
  • 4. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005; 129(1): 113-21[PubMed]
  • 5. Wiecek A, Adamczak M, Chudek J. Adiponectin--an adipokine with unique metabolic properties. Nephrol Dial Transplant. 2007; 22(4): 981-8[DOI][PubMed]
  • 6. Jee SH, Sull JW, Lee JE, Shin C, Park J, Kimm H, et al. Adiponectin concentrations: a genome-wide association study. Am J Hum Genet. 2010; 87(4): 545-52[DOI][PubMed]
  • 7. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001; 7(8): 941-6[DOI][PubMed]
  • 8. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001; 7(8): 947-53[DOI][PubMed]
  • 9. Abenavoli L, D. I. Renzo L , Guzzi PH, Pellicano R, Milic N, D. E. Lorenzo A . Non-alcoholic fatty liver disease severity, central fat mass and adinopectin: a close relationship. Clujul Med. 2015; 88(4): 489-93[DOI][PubMed]
  • 10. Stojsavljevic S, Gomercic Palcic M, Virovic Jukic L, Smircic Duvnjak L, Duvnjak M. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 2014; 20(48): 18070-91[DOI][PubMed]
  • 11. Abenavoli L, Peta V. Role of adipokines and cytokines in non-alcoholic fatty liver disease. Rev Recent Clin Trials. 2014; 9(3): 134-40[PubMed]
  • 12. Giby VG, Ajith TA. Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease. World J Hepatol. 2014; 6(8): 570-9[DOI][PubMed]
  • 13. Li HJ, Li CP, Zhang C, Zhong XL, Shi L. Association of Adiponectin gene polymorphisms and nonalcoholic fatty liver disease. Int J Clin Exp Med. 2015; 8(9): 16676-81[PubMed]
  • 14. Zhang C, Guo L. [Correlation of polymorphisms of adiponectin receptor 2 gene +33371Gln/Arg, cytochrome P4502E1 gene Rsa I and smoking with nonalcoholic fatty liver disease]. Nan Fang Yi Ke Da Xue Xue Bao. 2014; 34(10): 1481-7[PubMed]
  • 15. Zhou YJ, Zhang ZS, Nie YQ, Cao J, Cao CY, Li YY. Association of adiponectin gene variation with progression of nonalcoholic fatty liver disease: A 4-year follow-up survey. J Dig Dis. 2015; 16(10): 601-9[DOI][PubMed]
  • 16. Wang BF, Wang Y, Ao R, Tong J, Wang BY. AdipoQ T45 G and G276 T Polymorphisms and Susceptibility to Nonalcoholic Fatty Liver Disease Among Asian Populations: A Meta-Analysis and Meta-Regression. J Clin Lab Anal. 2016; 30(1): 47-57[DOI][PubMed]
  • 17. Tong G, Wang N, Leng J, Tong X, Shen Y, Yang J, et al. Common variants in adiponectin gene are associated with coronary artery disease and angiographical severity of coronary atherosclerosis in type 2 diabetes. Cardiovasc Diabetol. 2013; 12: 67[DOI][PubMed]
  • 18. Yang Y, Zhang F, Ding R, Wang Y, Lei H, Hu D. Association of ADIPOQ gene polymorphisms and coronary artery disease risk: a meta-analysis based on 12 465 subjects. Thromb Res. 2012; 130(1): 58-64[DOI][PubMed]
  • 19. Zhang B, Peng W, Li H, Lu Y, Zhuang J, Wang K, et al. Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions. Clin Biochem. 2013; 46(15): 1520-5[DOI][PubMed]
  • 20. Rickham PP. Human Experimentation. Code of Ethics of the World Medical Association. Declaration of Helsinki. Br Med J. 1964; 2(5402): 177[PubMed]
  • 21. Jian-gao F, Chinese Liver Disease A. Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition. Zhonghua Gan Zang Bing Za Zhi. 2010; 18(3): 163-6[PubMed]
  • 22. Lee Y, Kim BK, Lim YH, Kim MK, Choi BY, Shin J. The relationship between adiponectin and left ventricular mass index varies with the risk of left ventricular hypertrophy. PLoS One. 2013; 8(7)[DOI][PubMed]
  • 23. Kotronen A, Westerbacka J, Bergholm R, Pietilainen KH, Yki-Jarvinen H. Liver fat in the metabolic syndrome. J Clin Endocrinol Metab. 2007; 92(9): 3490-7[DOI][PubMed]
  • 24. Hermann TS, Li W, Dominguez H, Ihlemann N, Rask-Madsen C, Major-Pedersen A, et al. Quinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetes. J Clin Endocrinol Metab. 2006; 91(3): 1001-8[DOI][PubMed]
  • 25. Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M, et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med. 1999; 38(2): 202-6[PubMed]
  • 26. Handa P, Maliken BD, Nelson JE, Morgan-Stevenson V, Messner DJ, Dhillon BK, et al. Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis. Hepatology. 2014; 60(1): 133-45[DOI][PubMed]
  • 27. Kanu JS, Gu Y, Zhi S, Yu M, Lu Y, Cong Y, et al. Single nucleotide polymorphism rs3774261 in the AdipoQ gene is associated with the risk of coronary heart disease (CHD) in Northeast Han Chinese population: a case-control study. Lipids Health Dis. 2016; 15: 6[DOI][PubMed]
  • 28. Hashemi M, Hanafi Bojd H, Eskandari Nasab E, Bahari A, Hashemzehi NA, Shafieipour S, et al. Association of Adiponectin rs1501299 and rs266729 Gene Polymorphisms With Nonalcoholic Fatty Liver Disease. Hepat Mon. 2013; 13(5)[DOI][PubMed]
  • 29. Wang X, Zhang S, Chen Y, Liu H, Lan C, Chen X, et al. APM1 gene variants -11377C/G and 4545G/C are associated respectively with obesity and with non-obesity in Chinese type 2 diabetes. Diabetes Res Clin Pract. 2009; 84(3): 205-10[DOI][PubMed]
  • 30. Tokushige K, Hashimoto E, Noto H, Yatsuji S, Taniai M, Torii N, et al. Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease. J Gastroenterol. 2009; 44(9): 976-82[DOI][PubMed]
  • 31. Wang ZL, Xia B, Shrestha U, Jiang L, Ma CW, Chen Q, et al. Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population. J Endocrinol Invest. 2008; 31(12): 1086-91[DOI][PubMed]
  • 32. Hoefle G, Muendlein A, Saely CH, Risch L, Rein P, Koch L, et al. The -11377 C>G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in men. Thromb Haemost. 2007; 97(3): 451-7[PubMed]
  • 33. Zhang H, Mo X, Hao Y, Gu D. Association between polymorphisms in the adiponectin gene and cardiovascular disease: a meta-analysis. BMC Med Genet. 2012; 13: 40[DOI][PubMed]
  • 34. Foucan L, Maimaitiming S, Larifla L, Hedreville S, Deloumeaux J, Joannes MO, et al. Adiponectin gene variants, adiponectin isoforms and cardiometabolic risk in type 2 diabetic patients. J Diabetes Investig. 2014; 5(2): 192-8[DOI][PubMed]
  • 35. Schulze MB, Shai I, Rimm EB, Li T, Rifai N, Hu FB. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes. 2005; 54(2): 534-9[PubMed]
  • 36. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004; 291(14): 1730-7[DOI][PubMed]
  • 37. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002; 13(1): 134-41[PubMed]
  • 38. Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, Nagaretani H, et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension. 2003; 42(3): 231-4[DOI][PubMed]
  • 39. Hattori Y, Suzuki M, Hattori S, Kasai K. Globular adiponectin upregulates nitric oxide production in vascular endothelial cells. Diabetologia. 2003; 46(11): 1543-9[DOI][PubMed]
  • 40. Lopez-Jaramillo P. The Role of Adiponectin in Cardiometabolic Diseases: Effects of Nutritional Interventions. J Nutr. 2016; 146(2): 422S-6S[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments